Onderzoeker
Philip Vlummens
- Trefwoorden:Hematologie
- Disciplines:Analyse van next-generation sequence data, Hematologie, Bio-informatica data-integratie en netwerkbiologie
Affiliaties
- Vakgroep Inwendige ziekten en Pediatrie (Departement)
Lid
Vanaf1 okt 2018 → Heden - Vakgroep Inwendige ziekten (Departement)
Lid
Vanaf8 nov 2017 → 30 sep 2018 - Vakgroep Pediatrie en genetica (Departement)
Lid
Vanaf1 okt 2009 → 31 aug 2011
Publicaties
1 - 10 van 22
- Identifying patients with chronic lymphocytic leukemia without need of treatment : end of endless watch and wait?(2022)
Auteurs: Christian Brieghel, Veerle Galle, Rudi Agius, Caspar Da Cunha-Bang, Michael A. Andersen, Philip Vlummens, Mattias Mattsson, Richard Rosenquist, Karin E. Smedby, Carmen D. Herling, et al.
Pagina's: 369 - 378 - CS1-specific single-domain antibodies labeled with actinium-225 prolong survival and increase CD8+T cells and PD-L1 expression in multiple myeloma(2021)
Auteurs: Kim De Veirman, Janik Puttemans, Ahmet Krasniqi, Thomas Ertveldt, Heleen Hanssens, Ema Romao, Dirk Hose, Cleo Goyvaert, Philip Vlummens, Serge Muyldermans, et al.
- Daratumumab With Cetrelimab, an Anti-PD-1 Monoclonal Antibody, in Relapsed/Refractory Multiple Myeloma(2021)
Auteurs: Yael C. Cohen, Albert Oriol, Ka Lung Wu, Noa Lavi, Philip Vlummens, Carolyn Jackson, Wendy Garvin, Robin Carson, Wendy Crist, Jiayu Fu, et al.
Pagina's: 46 - + - Subgroup analysis of ICARIA-MM study in relapsed/refractory multiple myeloma patients with high-risk cytogenetics(2021)
Auteurs: Simon J. Harrison, Aurore Perrot, Adrian Alegre, David Simpson, Ming Chung Wang, Andrew Spencer, Sosana Delimpasi, Cyrille Hulin, Kazutaka Sunami, Thierry Facon, et al.
Pagina's: 120 - 131 - Compass : a prospective study comparing clinical evaluation with different geriatric screening methods in newly diagnosed elderly multiple myeloma patients(2021)Volume: 21
Auteurs: Michel Delforge, Jolien Raddoux, Cindy Kenis, Anneleen Vanhellemont, Philippe Mineur, Ellen Hoornaert, Ka Lung Wu, Jo Caers, Koen Van Eygen, Alain Kentos, et al.
Pagina's: S124 - S124 - Bortezomib-based induction followed by stem cell transplantation in light chain amyloidosis : results of the multicenter HOVON 104 trial(2019)
Auteurs: Monique C Minnema, Kazem Nasserinejad, Bouke Hazenberg, Ute Hegenbart, Philip Vlummens, Paula F Ypma, Nicolaus Kroeger, Ka Lung Wu, Marie Jose Kersten, M Ron Schaafsma, et al.
Pagina's: 2274 - 2282 - The exosomal transfer of acid sphingomyelinase contributes to drug resistance in multiple myeloma(2019)Volume: 134
Auteurs: Inge Oudaert, Sylvia Faict, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Lotte Jacobs, Kim De Veirman, Elke De Bruyne, Karel Fostier, et al.
Aantal pagina's: 1 - Response to therapy and the effectiveness of treatment with Selinexor and dexamethasone in patients with penta-exposed triple-class refractory myeloma who had plasmacytomas(2019)Volume: 134
Auteurs: Andrew J. Yee, Carol Ann Huff, Ajai Chari, Dan T. Vogl, Maria Gavriatopoulou, Ajay K. Nooka, Philippe Moreau, David Dingli, Craig E. Cole, Sagar Lonial, et al.
Aantal pagina's: 1 - The use of murine models for studying mechanistic insights of genomic instability in multiple myeloma(2019)
Auteurs: Philip Vlummens, Kim De Veirman, Eline Menu, Elke De Bruyne, Fritz Offner, Karin Vanderkerken, Ken Maes
- The transfer of sphingomyelinase contributes to drug resistance in multiple myeloma(2019)
Auteurs: Sylvia Faict, Inge Oudaert, Ludovic D'Auria, Jonas Dehairs, Ken Maes, Philip Vlummens, Kim De Veirman, Elke De Bruyne, Karel Fostier, Isabelle Vande Broek, et al.